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IS A LITERAL BACKTRANSLATION IN PRO DOCUMENTS
ALWAYSTHE BEST OPTION?
Houchin C1,Wild D2
1Oxford Outcomes Ltd, Oxford, Oxfordshire, UK, 2Oxford Outcomes
Ltd, Oxford, UK
OBJECTIVE: Back translation is considered by many to be an
integral part of the translation methodology for PRO documents.
But while the ISPOR Task Force paper (2005) describes it as a
critical component in the translation process without which ﬁnal
translations risk containing undetected different content from the
source document, it is criticised by McKenna et. al. (2005) for
having “no clear scientiﬁc basis” and for leading to potentially
misleading impressions of the translation. In contrast to the more
conceptual forward translation, using back translations as a tool
in the translation of PRO documents usually requires a more
literal translation to provide an accurate “window” into the
translation. This research compares literal with non-literal back
translations in PRO documents and aims to ascertain the circum-
stances in which each type of back translation would be most
appropriate. METHODS: A selection of PRO translation
projects has been reviewed based on the extent to which the back
translation was literal or not. RESULTS: Some literal translations
can be confusing and un-natural sounding while others suggest
the forward translation is incorrect where this is not necessarily
the case. Examples of both types of back translation include the
literal back translation of a Turkish phrase as “did your head
turn . . . over the last 24 hours?” This makes little sense because
the forward translation was idiomatic. Back translations of
the Ukrainian for “please tick one box” resulted in “please tick
one answer” (conceptual) and “please tick one square”
(literal)—here the literal translation is closer. The literal back
translation of the Czech for “seizure” shows an error in the
Czech where the conceptual back translation does not highlight
this. CONCLUSION: Literal back translations can be misleading
in idiomatic phrases but are usually more beneﬁcial for symp-
toms and health states.
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EQ-5D + VAS = PRO
Kind P, Chuang LH
University of York,York, UK
OBJECTIVE: Conﬂicting requirements are made for health
outcome measures reported in the USA and in Europe. Draft
guidance issued by the FDA takes the narrow prescriptive view
that a PRO is a measurement of any aspect of a patient’s health
status that comes directly from the patient (i.e. without the
interpretation of the patient’s responses by a physician or anyone
else). This runs counter to the requirement stipulated by NICE
that health beneﬁts should be weighted using population prefer-
ence values. The absolute need for hypothetical health state
valuations is questionable and this paper reports on a novel
scoring system for EQ-5D based entirely on self-assessments
obtained from “real” people. METHODS: Data were pooled
from several different UK sources, including national population
surveys conducted by post and patients self-assessment in clinical
studies. A total of 23,679 respondents contributed EQ-5D data
that included the health state deﬁned by respondent’s reported
problem level on the 5 dimensions (OSTATE) and the 0–100 VAS
rating of their own health status (EQ-5DVAS). A total of 139
EQ-5D health states were identiﬁed. The mean EQ-5DVAS was
computed for the 73 OSTATEs for which more than 5 observa-
tions were available. OLS regression analysis was performed on
the micro-level data taking the OSTATE problem levels as inde-
pendent variable and the self-rated VAS rating as the dependent
variable. RESULTS: The model ﬁt proved to be very good
(r2 = 0.985) when forced through the origin. Level decrements
within dimension were monotonic and consistent. A value for the
state dead of 12.0 obtained from similar UK national survey data
enabled these “real” VAS-based scores to be converted into the
0–1 format required in economic evaluation. CONCLUSION:
Values for EQ-5D based on own-health (“real”) ratings are
preferred to hypothetical values by some decision-makers. This
simple methodology contrasts markedly with the more complex
requirements of utility estimation techniques.
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DEVELOPMENT OF A STANDARDIZED CLASSIFICATION
SYSTEM FORTHETRANSLATIONS OF PRO INSTRUMENTS
Conway K1, Mear I2
1Mapi Research Trust, Lyon, France, 2Mapi Research Institute, Lyon,
France
OBJECTIVE: To facilitate the understanding of and the commu-
nication about the status of a translation of a Patient Reported
Outcome (PRO) instrument with instrument developers, users
and regulatory agencies, there is a need to develop a standard-
ized, universally recognized classiﬁcation system for translations.
This will help to summarize the methodology followed to
develop a speciﬁc language version, deﬁne which regulatory
requirements are met and describe possible outstanding work to
meet a required standard. METHODS: Based on the existing
classiﬁcation used for translations of the St George’s Respiratory
Questionnaire (SGRQ) established in collaboration with the
developer, we propose to revise, complete and extend this system
to the some 2000 translations ofﬁcially distributed for the 70
developers collaborating with our information centre in the fol-
lowing manner: a comparison of the existing classiﬁcation with
other possible classiﬁcation systems identiﬁed during a literature
search, a revision and ﬁnalization of the present classiﬁcation
integrating developer, user and regulatory input. RESULTS: The
present classiﬁcation system based on 61 translations of the
SGRQ is divided into four categories ranging from grade A
(ofﬁcial translation) to grade D (used when low standard trans-
lations require further work). The literature search is currently
on-going as well as the gathering of information from developers,
users and regulatory agencies. Results will be illustrated in the
presentation. CONCLUSION: The revised translation classiﬁca-
tion will integrate existing classiﬁcations, developer, user and
regulatory input. It will be based on the recognition that a
standardized translation methodology is key to ensure concep-
tual equivalence and cultural relevance across languages and
ultimately international comparison and pooling of data. The
revised classiﬁcation might then be extended to all translations in
the PRO ﬁeld and indeed may be used to deﬁne quality standards
for translations in particular settings (such as phase II or III trials,
international or national clinical trials).
RESEARCH ON METHODS & CONCEPTUAL
PAPERS—Study Design Studies
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EFFICIENCY OF HYBRID APPLICATIONS OF EXACT
COVARIATE MATCHING AND PROPENSITY SCORE
Yang G1, Stemkowski S2, Ernst F3
1IMS Health, Blue Bell, PA, USA, 2Premier Inc, Charlotte, NC, USA,
3Premier, Inc., Charlotte, NC, USA
OBJECTIVES: This study examines trade-offs between the high
dimensionality of covariate matching and high computational
efﬁciency from propensity score applications by comparing efﬁ-
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ciency among six distinct hybrid algorithms used with health care
data. METHODS: Six matching algorithms were examined. Each
combined covariate matching with a different propensity scoring
function: continuous factor, weighting factor, caliper, parenting
factor, nesting factor or partner. The algorithms were compared in
terms of 1:1 matching rate, computing time, bias balancing and
standardized difference. The inﬂuence of sample size variation on
stability and efﬁciency was considered. Paired T-test, Pearson
Chi-Square and Standardized Difference were adopted for assess-
ment. RESULTS: The superiority of some hybrid algorithms over
pure covariate matching was observed. In terms of matching rate,
the partner function reported the highest rate (99.7%), followed
by its function as a caliper (88.4%), while the parenting function
produced the lowest rate (59.5%). All others performed at a
similar level. Computing time varied, the most efﬁcient using the
propensity score as a parenting factor (00:25:10). The longest
reported times were seen when used as a weighting factor
(00:37:56) or caliper function (00:37:52). Differences are more
profound in large samples. In bias balancing tests, all algorithms
were balanced on categorical covariates except when the propen-
sity score was used as a partner or a caliper where each displayed
the lowest capability of producing p-values above 0.05. Signiﬁcant
reduction in standardized difference below 10% was indicative of
higher efﬁciency of the hybrid algorithms. Categorical covariates
produced values near zero despite the lower performance for the
partner approach. With increasing sample size, all investigations
performed as expected. CONCLUSION: Overall, these hybrid
applications exhibited greater efﬁciency in simultaneously over-
coming high dimensionality on covariate matching and reducing
variation in propensity score matching. Depending on data char-
acteristics and research proﬁles, each application has speciﬁc
merits in certain circumstances.
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SETTINGTHE OPTIMAL SCREENINGTOOLTHRESHOLD FOR
A CHRONIC UNDERDIAGNOSED ILLNESS:WHOSE BURDEN
MATTERS MOST?
Yu HT, Calimlim B, Dean BB, Dubois R
Cerner LifeSciences, Beverly Hills, CA, USA
Ankylosing spondylitis (AS) is a chronic disease with approxi-
mately 0.5% prevalence in the general population and 5%
among chronic back pain (CBP) sufferers. The disease typically
remains undiagnosed for over a decade which is problematic
since new treatments may alter the natural history. An AS screen-
ing instrument based upon patient reported data was developed
but selecting the optimal screening tool threshold is a critical
issue for discussion. Question items were identiﬁed from a litera-
ture review, patient focus groups, and an advisory board of
rheumatologists. A case-control study was conducted to test the
screening instrument among subjects with conﬁrmed AS (cases)
or CBP for3 months (controls). Question items were examined
in a multivariate logistic framework using best subsets modeling.
Receiver-operator characteristic analysis was conducted to deter-
mine optimal sensitivity (SE), speciﬁcity (SP), positive predictive
value (PPV), and negative predictive value (NPV) of the instru-
ment: AS prevalence set equal to 0.5% in the general population
and 5% among CBP sufferers. Responses from 102 cases and 214
controls were analyzed to develop a twelve-variable model. Sen-
sitivities ranging from 69.6% to 90.2% were associated with
speciﬁcities of 99.1% to 79.9%, respectively. Lowering sensitivi-
ties reduced the portion of false positives seen by the provider
from 95% to 20.3% (78.6% reduction) and 99.5% to 72.8%
(26.8% reduction) for the CBP and general populations, respec-
tively (SE = 69.6%, SP = 99.1%). Selecting the optimal screening
tool threshold depends on whose burden matters the most:
increasing sensitivity of the instrument would increase the prob-
ability of identifying patients with disease earlier and the ability
to improve AS patient well-being. However, this approach would
increase the economic burden (additional medical evaluations)
from the payer perspective, raise the patient care burden from the
rheumatologist perspective, and reduce quality of life for those
with false positives. We will discuss the trade-offs in this real
world example.
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TRANSLATING HETEROGENEITY BIAS FROM HEALTH
STATUS IN OUTCOMES STUDIES—USING LATENT CLASS
CLUSTER ANALYSIS AND LONGITUDINAL DATA
Ahn J
University of Southern California, Los Angeles, CA, USA
Ignoring heterogeneity in health may bias measurement of
intervention outcomes through confounding with intervention
of interest. If repeated observations on each subject are avail-
able, heterogeneity may be usefully included in outcomes
studies. We assume heterogeneous health status as a latent
index and multiple health proxies (and their correlations) are
used to estimate heterogeneous health grouping from the latent
index. For example, in a treatment effect study with longitudi-
nal data: 1) estimate K, the number of heterogeneous groups,
by latent class cluster analysis (LCCA) using health proxies of
each subject at each period, such as comorbidity indices, length
of hospitalization, total health care cost and so on; 2) if K > 1
(heterogeneity), estimate a treatment effect for each group and
compare the results across the groups; 3) if the effects vary over
the groups, heterogeneity can be translated by each group’s
health proﬁle (e.g. higher effectiveness found in sick but less
hospitalized group). This approach is relatively conservative
and combines multiple proxies objectively. Estimating K implies
a near consensus of model selection criteria such as Bayesian
Information Criteria (BIC), adjusted BIC, Akaike Information
Criteria (AIC), and consistent AIC; and bootstrap likelihood
ratio test (BLRT). Furthermore, it is difﬁcult to ﬁnd a practi-
cally useful K (say <5) because K tends to diverge to N (i.e.
each subject is a group), for a large enough sample size N.
Applying heterogeneity estimation to a claims data of 3260
subjects for two years found two heterogeneous groups (BIC,
adjusted BIC, consistent AIC, and BLRT all supported K = 2
except AIC). One group (N = 2841) was signiﬁcantly sicker
than the other group (N = 419) in Year 1 (and in Year 2) at
5%: Charlson Comorbidity Index 3.91 vs 0.11 (4.49 vs 0.14);
length of stay 0.87 vs 0.03 (1.04 vs 0); total cost $10690 vs
$245 ($11149 vs $184).
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EVIDENCE ANDVALUE: IMPACT ON DECISION MAKING—
THE EVIDEM FRAMEWORK AND POTENTIAL APPLICATIONS
Goetghebeur MM,Wagner M, Khoury H, Levitt R, Erickson LJ,
Rindress D
BioMedCom Consultants Inc, Montreal, QC, Canada
Develop a quantitative and practical methodology to structure,
objectify and facilitate health care decisionmaking. A concep-
tual framework was developed that segregated components of
decision-making into three categories: 1) quality of evidence
available; 2) intrinsic value of the health care intervention; and 3)
extrinsic or system related value, usually not directly quantiﬁ-
able. Using this framework, practical tools to assess health care
interventions were designed drawing on an extensive review of
the literature and of current decisionmaking processes for drug
reimbursement around the world. A matrix to quantify the
quality of evidence available for a health care intervention was
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